Lv41
440 积分 2024-01-06 加入
Hepcidin values can help predict the responsiveness of roxadustat for treating anemia in patients with chronic kidney disease
53分钟前
待确认
Randomized Trial of Pegmolesatide for the Treatment of Anemia in Patients With Nondialysis CKD
1小时前
已完结
Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide
1小时前
已完结
Peginesatide for Anemia in Chronic Kidney Disease
1小时前
已完结
Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction
8天前
已完结
Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction
15天前
已完结
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
17天前
已完结
Targeted sequencing of over 4000 hypertrophic cardiomyopathy (HCM) patients for mutations causing HCM and Fabry disease: HCM mutations frequent in patients with GLA later-onset mutations, polymorphisms, and variants
1个月前
已完结
Ratio of Fabry Disease in patients with idiopathic Left Ventricular Hypertrophy: A single center study from Turkey
1个月前
已完结
Genetic diseases
2个月前
已完结
皖公网安备34019202002308
